Outcome for adolescent and young adult patients with osteosarcoma: a report from the Children's Oncology Group.
about
UK guidelines for the management of bone sarcomasA summary of the osteosarcoma banking efforts: a report from the Children's Oncology Group and the QuadW FoundationOsteosarcoma in pediatric patients and young adults: a single institution retrospective review of presentation, therapy, and outcomeEpidemiology and therapies for metastatic sarcomaIn silico functional analyses and discovery of survival-associated microRNA signatures in pediatric osteosarcoma.Apurinic/apyrimidinic endonuclease 1 induced upregulation of fibroblast growth factor 2 and its receptor 3 induces angiogenesis in human osteosarcoma cells.Outcomes of Adolescent and Adult Patients with Lung Metastatic Osteosarcoma and Comparison of Synchronous and Metachronous Lung Metastatic GroupsChildren's Oncology Group's 2013 blueprint for research: adolescent and young adult oncology.Inhibition of protein phosphatase 2A with the small molecule LB100 overcomes cell cycle arrest in osteosarcoma after cisplatin treatment.Aberrant Retinoblastoma (RB)-E2F Transcriptional Regulation Defines Molecular Phenotypes of Osteosarcoma.Identification of Synergistic, Clinically Achievable, Combination Therapies for OsteosarcomaImprovement in High-Grade Osteosarcoma Survival: Results from 202 Patients Treated at a Single Institution in TaiwanActivation of PTHrP-cAMP-CREB1 signaling following p53 loss is essential for osteosarcoma initiation and maintenance.AYA in the USA. International Perspectives on AYAO, Part 5.Analysis of serum insulin growth factor-1 concentrations in localized osteosarcoma: a children's oncology group studyCytotoxic effects of 15d-PGJ2 against osteosarcoma through ROS-mediated AKT and cell cycle inhibition.Giant cell-rich osteosarcoma in long bones: clinical, radiological and pathological features.Clinical trial enrollment of adolescents and young adults with sarcoma.HSP70 desensitizes osteosarcoma cells to baicalein and protects cells from undergoing apoptosis.Disparities in Adolescents and Young Adults With CancerProteomic identification of 14-3-3ϵ as a linker protein between pERK1/2 inhibition and BIM upregulation in human osteosarcoma cells.Biologic activity of the novel small molecule STAT3 inhibitor LLL12 against canine osteosarcoma cell lines.Venous tumor thrombus from a pelvic osteosarcoma.Prognostic value of FDG-PET indices for the assessment of histological response to neoadjuvant chemotherapy and outcome in pediatric patients with Ewing sarcoma and osteosarcoma.pFAK-Y397 overexpression as both a prognostic and a predictive biomarker for patients with metastatic osteosarcoma.Systematic Screening Identifies Dual PI3K and mTOR Inhibition as a Conserved Therapeutic Vulnerability in Osteosarcoma.Emodin inhibits HMGB1-induced tumor angiogenesis in human osteosarcoma by regulating SIRT1.Influence of ezrin-shRNA in combination with HSP70 on the apoptosis and proliferation of osteosarcoma cells.Diagnostic assessment of osteosarcoma chemoresistance based on Virtual Clinical Trials.Experience of pediatric osteosarcoma of the extremity at a single institution in Taiwan: prognostic factors and impact on survival.Osteosarcoma in patients younger than 12 years old without metastases have similar prognosis as adolescent and young adults.Response Evaluation Criteria in Solid Tumors (RECIST) following neoadjuvant chemotherapy in osteosarcoma.Primary metastatic osteosarcoma: results of a prospective study in children given chemotherapy and interleukin-2.FDG PET/CT appearance of local osteosarcoma recurrences in pediatric patients.The extremity localized classic osteosarcomas have better survival than the axial non-classics.Prognostic Value of Vascular Invasion in Pediatric Osteosarcomas.miR-34 inhibits growth and promotes apoptosis of osteosarcoma in nude mice through targetly regulating TGIF2 expression.18F-FDG Uptake During Early Adjuvant Chemotherapy Predicts Histologic Response in Pediatric and Young Adult Patients with Osteosarcoma.Adenovirus-mediated small interfering RNA targeting ezrin induces apoptosis and inhibits metastasis of human osteosarcoma MG-63 cellsRadiological characteristics and predisposing factors of venous tumor thrombus in pelvic osteosarcoma: A mono-institutional retrospective study of 115 cases
P2860
Q26752425-712EDEC6-26CE-42AF-82A8-8337EF5CB1E0Q28386370-7FA428C4-FA8F-4713-873D-B3AB61318770Q33614621-47CEF4A4-6CD2-41CA-9589-8F8ED02396DCQ34652142-F8BFC32E-15A3-4CB7-AB40-B1900758609DQ34781386-4BAE7D5C-4537-4A85-87EB-34025754AD3AQ35051513-8ACA0DFD-A34A-4BA2-AA99-262A73EFE16DQ36014443-E441FAF9-1F4E-4514-89E8-EC4FFE65E6A9Q36157250-3E80A841-4B93-45BA-91C8-B70E1C4F2BEFQ36180744-83238070-816B-4CB2-A3A2-07FFBBD191FAQ36301216-D0A56353-5764-4066-872E-BC9E14799821Q36316518-570B2DBA-4C30-4ADD-B454-5FFC95F2313DQ36822586-30FB9797-3887-418D-8AC5-D9DBEC9D2A23Q36862527-49948C43-45DB-4958-B23A-B70D8DD7F145Q37406641-7F44A1E1-E162-4C44-AF5D-588C83B891A0Q37624249-B1937825-4391-464B-A885-06720F5EF06EQ37718423-2896A348-6B86-4E38-BAC3-62E7EB64E63AQ38110244-D6BFC1BA-467A-458B-973D-A419211E4DA7Q38685233-859C6E93-E35A-43D8-AA26-EEE967DD4CB4Q38993208-6ABF0984-A34F-4F55-9DAF-A89D1EF8DB6AQ39008035-F0EA122D-D37B-417A-9799-BFEE8E4352E1Q39023037-7423A75E-4C11-474D-9EE9-D1F99F07E481Q39225305-0F68BCCB-AB35-40BD-83FA-2C77FA5E61D5Q39664957-C5DC686B-1EAB-4FF0-8601-AC9E78734B10Q41523153-1FFAB64B-1136-42CD-8BD3-71A68A6D1308Q41533133-C544EF26-2ABB-4683-9F45-7701623E416EQ41764229-3FD88488-BE3C-484B-8278-2BD007310DF6Q41995659-602026B9-CFF0-4B88-98FE-31FFBE2A1090Q42370628-6D82BB07-79FB-44F4-B2CE-588A3FA93F3DQ42843612-D54604C2-7653-44B8-AF51-5A5A213BD028Q43588156-B83323BF-B3FA-4FEB-9338-BD7D2431EF9AQ43645139-1D9436FA-5F8F-4449-851E-925940BE441AQ48101407-23759377-C09F-4F08-B3F9-14858C54AB86Q48378796-9542975C-73A9-4C1C-87AD-E4ECE0866F1FQ50193590-D4CB65AF-0BE3-423C-8EC2-0D6FC77A496DQ50315172-F36B316D-C1CF-41C4-AE77-E943EEB45835Q50849056-6AD12B76-4FD6-44E2-A232-8F50537F7F06Q55121974-D4D27D55-39A2-419C-8269-A0AC3AAE2D4DQ55362893-855EFEEC-9E36-45FE-A16D-BDCBDB7CA410Q58693569-82557CDE-5F03-4E54-BE5E-6993C067D6B0Q58709616-A11B9ED7-14A0-4D1C-A9BA-0426D7052FBE
P2860
Outcome for adolescent and young adult patients with osteosarcoma: a report from the Children's Oncology Group.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Outcome for adolescent and you ...... the Children's Oncology Group.
@ast
Outcome for adolescent and you ...... the Children's Oncology Group.
@en
Outcome for adolescent and you ...... the Children's Oncology Group.
@nl
type
label
Outcome for adolescent and you ...... the Children's Oncology Group.
@ast
Outcome for adolescent and you ...... the Children's Oncology Group.
@en
Outcome for adolescent and you ...... the Children's Oncology Group.
@nl
prefLabel
Outcome for adolescent and you ...... the Children's Oncology Group.
@ast
Outcome for adolescent and you ...... the Children's Oncology Group.
@en
Outcome for adolescent and you ...... the Children's Oncology Group.
@nl
P2093
P2860
P50
P356
P1433
P1476
Outcome for adolescent and you ...... the Children's Oncology Group.
@en
P2093
Cindy L Schwartz
David H Ebb
Donald A Barkauskas
Holcombe E Grier
Katherine A Janeway
Mark D Krailo
Neyssa Marina
P2860
P304
P356
10.1002/CNCR.27414
P407
P577
2012-01-17T00:00:00Z